PDE5 inhibitors blunt inflammation in Benign Prostatic Hyperplasia (BPH): A potential mechanism of action for PDE5 inhibitors in Low Urinary Tract Symptoms (LUTS)

被引：0
|
作者：
Santi, R. [1 ]
Vignozzi, L. [1 ]
Gacci, M. [1 ]
Pepi, M. [1 ]
Baroni, G. [1 ]
Carini, M. [1 ]
Maggi, M. [1 ]
Nesi, G. [1 ]
机构：
[1] Univ Florence, I-50121 Florence, Italy
来源：
VIRCHOWS ARCHIV | 2013年 / 463卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：349 / 349
页数：1
相关论文
共 50 条
  • [31] PDE5 inhibitors and permanent visual loss
    Tomsak, R
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2005, 17 (06) : 547 - 549
  • [32] PDE5 inhibitors: looking beyond ED
    Jackson, G
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (03) : 159 - 160
  • [33] Further reassurance regarding PDE5 inhibitors
    Hackett, G. I.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (09) : 1426 - 1427
  • [34] PDE5 inhibitors beyond erectile dysfunction
    P Sandner
    J Hütter
    H Tinel
    K Ziegelbauer
    E Bischoff
    International Journal of Impotence Research, 2007, 19 : 533 - 543
  • [35] PDE5 inhibitors in diabetic peripheral neuropathy
    Hackett, G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (09) : 1123 - 1126
  • [36] The efficacy of PDE5 inhibitors in diabetic patients
    Swiecicka, Agnieszka
    ANDROLOGY, 2023, 11 (02) : 245 - 256
  • [37] Effect of PDE5 inhibitors in diabetic neuropathy
    Kulkarni, Shrinivas K.
    Patil, Chandrashekhar S.
    Singh, Vijay P.
    INFLAMMATION RESEARCH, 2005, 54 : S192 - S192
  • [38] Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma
    Bisegna, C.
    Gravina, G. L.
    Pierconti, F.
    Martini, M.
    Larocca, L.
    Rossi, P.
    Grimaldi, P.
    Dolci, S.
    Di Stasi, S.
    Jannini, E. A.
    ANDROLOGY, 2020, 8 (02) : 427 - 433
  • [39] Oral PDE5 Inhibitors for Erectile Dysfunction
    Murphy, Matthew
    Demers, Jill M.
    Ostroff, Marissa L.
    Ostroff, Jared L.
    US PHARMACIST, 2018, 43 (06) : 29 - 33
  • [40] PDE5 inhibitors as potential tools in the treatment of cystic fibrosis
    Noel, Sabrina
    Dhooghe, Barbara
    Leal, Teresinha
    FRONTIERS IN PHARMACOLOGY, 2012, 3
12345